SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2004
GENVEC, INC.
(Exact Name of Issuer as Specified in Charter)
| | | | | |
| Delaware | | 0-24469 | | 23-2705690 |
| |
| |
|
| (State or other jurisdiction | | (Commission File Number) | | (I.R.S. Employer |
| of incorporation) | | | | Identification No.) |
65 West Watkins Mill Road
Gaithersburg, MD
(Address of principal executive offices)
20878
(Zip code)
(240) 632 0740
(Registrant’s telephone number, including area code)
Item 7. Financial Statements and Exhibits.
(c) Exhibits
99.1 Text of Press Release, dated August 5, 2004.
Item 12. Results of Operations and Financial Condition.
On August 5, 2004, GenVec, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2004 and updates on the Company’s clinical programs. The press release is furnished as Exhibit 99.1 hereto.
The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to liability under such Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in any such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GENVEC, INC.
/s/ Jeffrey W. Church
———————————————
Jeffrey W. Church
Chief Financial Officer, Treasurer
and Corporate Secretary
Date: August 5, 2004
